Covid19 Clinical Trial
Official title:
Psychiatric Consultation for COVID-19 Patients
In this study, the content and results of the psychiatric consultation on patients in Corona
Care Ward were verified retroactively, and the effects of COVID-19 patients' emotional state
and psychological support and crisis intervention were assessed on their emotional state.
Patients who are admitted to the COVID-19 care unit of the Catholic University of Daegu
Hospital are subject to consultation with the psychiatrist. By retrospectively reviewing the
medical records of the request and the results of the subjects, We collected
Socio-demographic information, medical severity (oxygen saturation, chest x-ray readings,
medication being administered), clinical psychological scale (PHQ-9, GAD-7, PC-PTSD-5, AIS,
P4, SF-36, SCL-90-R) This study evaluates whether there is a difference in psychological
scale according to differences in socio-demographic status and medical severity, and compares
psychological measures before and after referral to mental health medicine to evaluate the
effectiveness of psychiatric counseling.
Patients and medical workers in the event of an pandemic infectious disease usually
experience extreme fear, which requires quick and immediate management of mental health. In
2015, the risk of post-traumatic stress disorder in isolated MERS patients and medical staff
was very high. Even 4 ~ 6 months after the quarantine was over, anxiety was still lingering
in 3% percent of patients and anger in 6.4 % of patients. The negative emotions and stress
experienced by the medical staff for MERS patients were characterized by such events as
mistakes and delays caused by communication problems. Also, people who were not infected with
MERS experienced anxiety at 7.6 percent and anger at 16.6 percent during the quarantine
period.Therefore, the need for psychological support for infected patients, isolated people,
medical staff and the general public had been proposed during these infectious disease fad
periods since MERS. Since the recent spread of coronavirus infection-19 (COVID-19) that began
in Wuhan, China in December 2019, thousands of confirmed and dozens of deaths have been
reported in South Korea and the number is on the rise. Thus, quarantine measures are
currently being taken in Korea to reduce and treat the spread of COVID-19. Thus,
psychological support and crisis intervention are needed in the early stages of stressful
times to reduce anxiety, depression and post-traumatic stress disorder. In response, Daegu
Catholic university hospital psychiatry department conducted active psychiatric counseling
for medical patients who are hospitalized in Corona's management hospital for confirmation of
coronavirus infection. In this study, the content and results of the psychiatric consultation
on patients in Corona Care Ward were verified retroactively, and the effects of COVID-19
patients' emotional state and psychological support and crisis intervention were assessed on
their emotional state.
Patients who are admitted to the COVID-19 care unit of the Catholic University of Daegu
Hospital are subject to consultation with the psychiatrist. By retrospectively reviewing the
medical records of the request and the results of the subjects, We collected
Socio-demographic information, medical severity (oxygen saturation, chest x-ray readings,
medication being administered), clinical psychological scale (PHQ-9, GAD-7, PC-PTSD-5, AIS,
P4, SF-36, SCL-90-R) This study evaluates whether there is a difference in psychological
scale according to differences in socio-demographic status and medical severity, and compares
psychological psychological measures before and after referral to mental health medicine to
evaluate the effectiveness of psychiatric counseling.
;
Status | Clinical Trial | Phase | |
---|---|---|---|
Completed |
NCT05047692 -
Safety and Immunogenicity Study of AdCLD-CoV19-1: A COVID-19 Preventive Vaccine in Healthy Volunteers
|
Phase 1 | |
Recruiting |
NCT04395768 -
International ALLIANCE Study of Therapies to Prevent Progression of COVID-19
|
Phase 2 | |
Completed |
NCT04508777 -
COVID SAFE: COVID-19 Screening Assessment for Exposure
|
||
Terminated |
NCT04555096 -
A Trial of GC4419 in Patients With Critical Illness Due to COVID-19
|
Phase 2 | |
Completed |
NCT04506268 -
COVID-19 SAFE Enrollment
|
N/A | |
Completed |
NCT04961541 -
Evaluation of the Safety and Immunogenicity of Influenza and COVID-19 Combination Vaccine
|
Phase 1/Phase 2 | |
Active, not recruiting |
NCT04546737 -
Study of Morphological, Spectral and Metabolic Manifestations of Neurological Complications in Covid-19 Patients
|
N/A | |
Not yet recruiting |
NCT04543006 -
Persistence of Neutralizing Antibodies 6 and 12 Months After a Covid-19
|
N/A | |
Completed |
NCT04532294 -
Safety, Tolerability, Pharmacokinetics, and Immunogenicity of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2/COVID-19) Neutralizing Antibody in Healthy Participants
|
Phase 1 | |
Terminated |
NCT04542993 -
Can SARS-CoV-2 Viral Load and COVID-19 Disease Severity be Reduced by Resveratrol-assisted Zinc Therapy
|
Phase 2 | |
Terminated |
NCT04581915 -
PHRU CoV01 A Trial of Triazavirin (TZV) for the Treatment of Mild-moderate COVID-19
|
Phase 2/Phase 3 | |
Completed |
NCT04494646 -
BARCONA: A Study of Effects of Bardoxolone Methyl in Participants With SARS-Corona Virus-2 (COVID-19)
|
Phase 2 | |
Completed |
NCT04387292 -
Ocular Sequelae of Patients Hospitalized for Respiratory Failure During the COVID-19 Epidemic
|
N/A | |
Completed |
NCT04537663 -
Prevention Of Respiratory Tract Infection And Covid-19 Through BCG Vaccination In Vulnerable Older Adults
|
Phase 4 | |
Completed |
NCT04507867 -
Effect of a NSS to Reduce Complications in Patients With Covid-19 and Comorbidities in Stage III
|
N/A | |
Not yet recruiting |
NCT04527211 -
Effectiveness and Safety of Ivermectin for the Prevention of Covid-19 Infection in Colombian Health Personnel
|
Phase 3 | |
Not yet recruiting |
NCT05038449 -
Study to Evaluate the Efficacy and Safety of Colchicine Tablets in Patients With COVID-19
|
N/A | |
Completed |
NCT04979858 -
Reducing Spread of COVID-19 in a University Community Setting: Role of a Low-Cost Reusable Form-Fitting Fabric Mask
|
N/A | |
Completed |
NCT04610502 -
Efficacy and Safety of Two Hyperimmune Equine Anti Sars-CoV-2 Serum in COVID-19 Patients
|
Phase 2 | |
Active, not recruiting |
NCT06042855 -
ACTIV-6: COVID-19 Study of Repurposed Medications - Arm G (Metformin)
|
Phase 3 |